ASHLEY ALDERFER: Open Payments
NPI 1134560154 · THORNDALE, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,176 in 61 payments from 22 companies in 2025. Trend: 2023 $1,714 · 2024 $1,027 · 2025 $1,176
Food & beverage: $1,176
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 10 | $174 |
| ABBVIE INC. | 6 | $112 |
| Lundbeck LLC | 4 | $88 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 5 | $87 |
| Abbott Laboratories | 4 | $83 |
| Lilly USA, LLC | 4 | $72 |
| GlaxoSmithKline, LLC. | 4 | $68 |
| Dexcom, Inc. | 2 | $67 |
| AstraZeneca Pharmaceuticals LP | 3 | $57 |
| Exact Sciences Corporation | 2 | $45 |
Products named: REXULTI, CAPLYTA, FREESTYLE LIBRE 3, VRAYLAR, Wegovy, Dexcom G6 Transmitter, Rybelsus, MOUNJARO.
Industry payments across PA — which companies pay providers there.
